COVID-19-related 30-day mortality was numerically higher in the first compared with the second wave of the pandemic, though this observed difference did not reach statistical significance (22.1% versus 17.1%, P = 0.13).
← all excerpts
Changes in anticancer treatment plans in patients with solid cancer hospitalized with COVID-19: analysis of the nationwide BSMO-COVID registry providing lessons for the future.
1
0.1300
0.1300